The increasing demand for specific immunological study and therapeutic design has spurred significant improvements in recombinant growth factor generation. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique physiological roles, are frequently manufactured using various expression platforms, including microbial hosts, mammalian cell populations, a